Table 1.
Patients’ demographics and summary of clinical results.
| Characteristics | Facial Erythema Mainly with Acne | Facial Erythema Mainly with Rosacea | Total |
|---|---|---|---|
| Total patients, n | 11 | 15 (ETR:10, PPR:3, Mixed:2) |
26 |
| Age, y (mean ± SD) | 28.6 ± 6.2 | 43.2 ± 8.4 | 37.0 ± 10.4 |
| Sex ratio (male : female) |
6 : 5 | 3 : 12 | 9 : 17 |
| Baseline erythema index | 523.0 ± 147.8 | 450.7 ± 91.7 | 461.8 ± 97.8 |
| Erythema index at 6 weeks follow-up | 493.5 ± 121.6 (p = 0.18) |
409.1 ± 59.3 (p = 0.023) |
422.1 ± 71.9 (p = 0.010) |
| Baseline TEWL index | 20.8 ± 6.3 | 26.9 ± 16.7 | 24.3 ± 13.5 |
| TEWL index at 6 weeks follow-up | 18.6 ± 6.0 (p = 0.290) |
19.2 ± 5.0 (p = 0.036) |
18.9 ± 5.3 (p = 0.020) |
| Baseline CEA score | 2.72 ± 0.90 | 2.40 ± 0.51 | 2.53 ± 0.71 |
| CEA score at 6 weeks follow-up | 1.54 ± 0.93 (p = 0.023) |
1.67 ± 0.62 (p = 0.002) |
1.61 ± 0.75 (p < 0.001) |
| Baseline SSQ score | 2.82 ± 0.87 | 2.53 ± 0.83 | 2.65 ± 0.84 |
| SSQ score at 6 weeks follow-up | 2.27 ± 0.78 (p = 0.058) |
2.06 ± 0.79 (p = 0.020) |
2.15 ± 0.78 (p = 0.003) |
ETR: erythematotelangiectatic rosacea; PPR: papulopustular rosacea; TEWL: transepidermal water loss; CEA: clinician’s erythema assessment scores; and SSQ: subject satisfaction questionnaire scores.